Renovus Capital Partners has announced it has completed a majority investment in Thomas J Paul (TJP).
TJP, based in Rydal, Pa., is a healthcare marketing communications and sales training consulting firm. Founded in 1972, the company states that it supports several global pharmaceutical companies in payer marketing as well as access and affordability programs.
Renovus, based in Philadelphia, is a lower middle market private equity firm that invests in a few sectors, including healthcare services. Founded in 2010, the firm invests across a range of healthcare companies, including those in life sciences commercialization, IT, revenue cycle management and behavioral health.
Terms of the acquisition were not disclosed.